Janusmed Sex and Gender

  Search help

2017-06-28 The sex of animals impact on biomedical research
A recent publication in Nature Communications has quantified the differences between male and female mice. The importance of the sex was greater than previously thought. The findings show that sex should be taken into account when designing and analyzing animal studies, regardless of research field.

2017-06-20 Serious adverse events more common in women
The proportion of reports of serious adverse events was higher for women than men in Sweden in 2016, according to the Medical Products Agencys annual report (in Swedish). The number of serious reports for women was highest in the age group 18-64 years, while the corresponding number for men was in the age group 65 years and older. The most common substances in serious reports from healthcare staff were the anticoagulant drugs warfarin, apixaban and rivaroxaban.

2017-04-24 Men and women with psoriasis are treated differently
Data from the Stockholm County Council during the period 2001-2016 showed that men with psoriasis recieved more systemic drugs, biological drugs and light therapy than women. Read more in the latest issue of Evidens (in Swedish).


Janusmed Sex & Gender is a knowledge bank with structured information on sex and gender aspects on drug treatment. The information is aimed towards healthcare personal. It is possible to search on generic names in English and trade names of drug products on the Swedish market. For detailed information on how to search, click on Search help in the blue search field. The purpose of the web site is to improve drug treatment by providing information on whether drug choice or drug dosing need to consider the patient's sex.

Please note that Janusmed Sex & Gender does not include information on teratogenic effects or compatibility with breast feeding. For this information, please consult the databases Drugs and Birth Defects and Drugs and Breastfeeding, respectively (in Swedish).

The Health and Medical Care Administration at the Stockholm County Council is responsible for the web site. The work is done in collaboration between the Drug Therapeutic Committee in Stockholm County Council, Department of Clinical Pharmacology, Karolinska University Hospital and Centre for Gender Medicine, Karolinska Institutet.

Comments are appreciated, contact us via janusredaktionen@sll.se